Literature DB >> 25433419

A retrospective statistical analysis of the late complications associated with central venous port placements.

Shingo Okada1, Akihiko Shiraishi, Yuki Yamashiro, Tatsuro Inoue, Daisuke Tsuge, Mari Aida, Ryohei Kuwatsuru.   

Abstract

PURPOSE: Central venous (CV) ports are being used increasingly in both hospital and home care settings. Here, we investigated the rates and causes of CV port complications.
MATERIALS AND METHODS: We retrospectively analyzed the placement of 264 consecutive CV ports in 239 consecutive patients admitted to our hospital between September 2009 and February 2012. All CV ports were inserted under fluoroscopy and ultrasound visualization by interventional radiologists using maximum barrier precautions. CV port complications were checked in detail and analyzed statistically.
RESULTS: Total indwelling time for all CV ports was 51,033 catheter days. Of the 264 CV ports assessed, 50 were removed during the study period because of any complication and 147 remained at the end of the study period. In 33 cases, the patient died before the end of the study. Of the 50 patients who underwent CV port removal, 13 were diagnosed as having catheter-related bloodstream infection (CRBSI). The total rate of CV port removal because of any complication was 0.98 cases per 1,000 catheter days, that of catheter troubles was 0.22 cases per 1,000 catheter days and that of CRBSI was 0.25 cases per 1,000 catheter days. Steroid administration and total parenteral nutrition (TPN) were associated with increased rates of infection. It seems that chemotherapy and indwelling time were also considered important factors.
CONCLUSION: Steroid administration and TPN were associated with increased rates of infection. In addition, patients receiving chemotherapy or whose CV ports are left in place for a long time should be carefully observed to decrease these complications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25433419     DOI: 10.1007/s11604-014-0375-0

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  12 in total

1.  Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients.

Authors:  H Lorch; M Zwaan; C Kagel; H D Weiss
Journal:  Cardiovasc Intervent Radiol       Date:  2001 May-Jun       Impact factor: 2.740

2.  Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems.

Authors:  H J Kock; M Pietsch; U Krause; H Wilke; F W Eigler
Journal:  World J Surg       Date:  1998-01       Impact factor: 3.352

3.  Subclavian vein versus arm vein for totally implantable central venous port for patients with head and neck cancer: a retrospective comparative analysis.

Authors:  Akio Akahane; Miyuki Sone; Shigeru Ehara; Kenichi Kato; Ryoichi Tanaka; Tatsuhiko Nakasato
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12-03       Impact factor: 2.740

Review 4.  The complications of central venous access systems: a study of 218 patients.

Authors:  J R Torramadé; J A Cienfuegos; J L Hernández; F Pardo; C Benito; J González; E Balén; V de Villa
Journal:  Eur J Surg       Date:  1993 Jun-Jul

5.  Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.

Authors:  R Biffi; F de Braud; F Orsi; S Pozzi; S Mauri; A Goldhirsch; F Nolè; B Andreoni
Journal:  Ann Oncol       Date:  1998-07       Impact factor: 32.976

6.  Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: a 5-year single-institution retrospective study.

Authors:  Philip Kuriakose; Gerardo Colon-Otero; Ricardo Paz-Fumagalli
Journal:  J Vasc Interv Radiol       Date:  2002-02       Impact factor: 3.464

7.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

8.  Evaluation of infectious complications of the implantable venous access system in a general oncologic population.

Authors:  Lilu Chang; Jir-Shiong Tsai; Shin-Ju Huang; Chiang-Ching Shih
Journal:  Am J Infect Control       Date:  2003-02       Impact factor: 2.918

9.  Combined ultrasound and fluoroscopy guided port catheter implantation--high success and low complication rate.

Authors:  Bernhard Gebauer; Michael El-Sheik; Michael Vogt; Hans-Joachim Wagner
Journal:  Eur J Radiol       Date:  2009-03       Impact factor: 3.528

Review 10.  Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature.

Authors:  J Vardy; K Engelhardt; K Cox; J Jacquet; A McDade; M Boyer; P Beale; M Stockler; R Loneragan; B Dennien; R Waugh; S J Clarke
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more
  3 in total

1.  Late complications associated with totally implantable venous access port implantation via the internal jugular vein.

Authors:  Shigeaki Tsuruta; Yasutomo Goto; Hideo Miyake; Hidemasa Nagai; Yuichiro Yoshioka; Norihiro Yuasa; Junichi Takamizawa
Journal:  Support Care Cancer       Date:  2019-11-14       Impact factor: 3.603

2.  Effectiveness of a flow confirmation study of a central venous port of the upper arm versus the chest wall in patients with suspected system-related mechanical complications.

Authors:  Hiroyuki Tokue; Azusa Tokue; Yoshito Tsushima
Journal:  World J Surg Oncol       Date:  2022-03-22       Impact factor: 2.754

3.  Outcomes following port-a-catheter placement in the Medicare population.

Authors:  Syed I Khalid; Samantha Maasarani; Rachyl M Shanker; Aaron Lee Wiegmann; Rita Wu; Nicholas J Skertich; Samantha L Terranella; Laura DeCesare; Edie Y Chan
Journal:  Surg Open Sci       Date:  2020-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.